AbbVie Inc - Enterprise Value To Ebitda Ratio

AbbVie Inc's Fiscal Year is From January To December.

The item "Enterprise-Value-To-Ebitda-Ratio" stands at 35.59 as of 09/30/2025, the highest value at least since 06/30/2022, the period currently displayed.

As of the end of AbbVie Inc's third quarter, the item "Enterprise Value To Ebitda Ratio" stands at 35.59. This represents an increase of 32.75 percent compared to it's value at the end of it's second quarter .


Regarding the One-Year-Change of the series, the current value constitutes an increase of 65.39 percent compared to the value the year prior.
The 1 year change in percent is 65.39.
The 3 year change in percent is 221.35.

The Serie's long term average value is 18.94. It's latest available value, on 09/30/2025, is 87.87 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 09/30/2022, to it's latest available value, on 09/30/2025, is +221.35%.
The Serie's change in percent from it's maximum value, on 09/30/2025, to it's latest available value, on 09/30/2025, is 0.0%.